Scinai Immunotherapeutics (SCNI) Other Working Capital Changes (2018 - 2024)
Scinai Immunotherapeutics' (SCNI) quarterly Other Working Capital Changes came in at -$38000.0 in Q4 2024, up 33.33% quarter-over-quarter from -$57000.0 in Q3 2024.
Scinai Immunotherapeutics (SCNI) Other Working Capital Changes (2018 - 2024) Analysis & Trends
Scinai Immunotherapeutics has disclosed Other Working Capital Changes across 7 years of filings, most recently posting -$38000.0 for Q4 2024.
- Other Working Capital Changes for Q4 2024 came in at -$38000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was -$284000.0 (changed N/A YoY), and the FY2025 annual result was -$89000.0, up 68.66% from the prior year.
- Other Working Capital Changes came in at -$38000.0 for Q4 2024 at Scinai Immunotherapeutics, up from -$57000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $140000.0 in Q4 2021 to a low of -$320000.0 in Q2 2022.
- The 5-year median for Other Working Capital Changes is -$92000.0 (2021), against an average of -$137176.5.
- Across the five-year window, Other Working Capital Changes soared 144.87% in 2021 and tumbled 2775.0% in 2024, its largest moves.
- Scinai Immunotherapeutics' Other Working Capital Changes stood at -$312000.0 in 2020, then surged by 144.87% to $140000.0 in 2021, then tumbled by 218.57% to -$166000.0 in 2022, then jumped by 97.59% to -$4000.0 in 2023, then plunged by 850.0% to -$38000.0 in 2024.
- The last three Other Working Capital Changes figures came in at -$38000.0 (Q4 2024), -$57000.0 (Q3 2024), and -$115000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -38,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Sep 30, 2024 | -57,000.00 |
| Sep 30, 2024 | -57,000.00 |
| Jun 30, 2024 | -115,000.00 |
| Jun 30, 2024 | -115,000.00 |
| Mar 31, 2024 | -74,000.00 |
| Mar 31, 2024 | -74,000.00 |
| Jun 30, 2023 | -4,000.00 |
| Jun 30, 2023 | -4,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | -166,000.00 |
| Dec 31, 2022 | -166,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | -320,000.00 |
| Jun 30, 2022 | -320,000.00 |
| Mar 31, 2022 | -62,000.00 |
| Mar 31, 2022 | -62,000.00 |